Literature DB >> 32433789

The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paper.

Pamela McKay1, Matthew R Wilson1, Sridhar Chaganti2, Jeffery Smith3, Christopher P Fox4,5, Kate Cwynarski6.   

Abstract

Entities:  

Keywords:  CNS Prophylaxis; CNS Relapse; Chemotherapy; DLBCL; Non-Hodgkin lymphoma

Year:  2020        PMID： 32433789     DOI： 10.1111/bjh.16866

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Central nervous system prophylaxis in diffuse large B-cell lymphoma: a race to the bottom.

Authors:  Mark Roschewski
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

Review 2.  SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma.

Authors:  Jillian Simard; Mark Roschewski
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2022-06-06

3.  Renal involvement of lymphomas proven by kidney biopsy: report of 10 cases from a tertiary care center and comparison with the literature.

Authors:  Fanny Urbain; Sophie Ferlicot; Laurence Rocher; Florent L Besson; Léa Gomez; Jean-Marie Michot; Thierry Lazure; Xavier Mariette; Gaëtane Nocturne; Olivier Lambotte; Mohamad Zaidan; Nicolas Noel
Journal:  Int J Hematol       Date:  2022-07-13       Impact factor: 2.319

Review 4.  HIV/AIDS Associated Lymphoma: Review.

Authors:  Ayenew Berhan; Biruk Bayleyegn; Zegeye Getaneh
Journal:  Blood Lymphat Cancer       Date:  2022-04-29

5.  Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.

Authors:  Takafumi Shichijo; Hiro Tatetsu; Kisato Nosaka; Yusuke Higuchi; Yoshitaka Kikukawa; Yoshitaka Inoue; Kosuke Toyoda; Jun-Ichirou Yasunaga; Masao Matsuoka
Journal:  EJHaem       Date:  2022-02-08

6.  Central nervous system relapse in diffuse large B lymphoma: a retrospective cohort study

Authors:  Fernando Warley; Nancy Cristaldo; Giuliana Colucci; Victoria Otero
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2021-06-28

7.  Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.

Authors:  Adam J Olszewski; Anna D Chorzalska; Max Petersen; Thomas A Ollila; Adam Zayac; Habibe Kurt; Diana O Treaba; John L Reagan; Andrew Hsu; Pamela C Egan; James Butera; Rabin Niroula; John Vatkevich; Jordan Robison; Ilyas Sahin; Allison P Jacob; Chelsea D Mullins; Patrycja M Dubielecka
Journal:  Blood Adv       Date:  2021-12-28

8.  High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma.

Authors:  Shin Yeu Ong; Sanjay de Mel; Nicholas Francis Grigoropoulos; Yunxin Chen; Yan Chin Tan; Melinda Si Yun Tan; Lawrence Cheng Kiat Ng; Yuh Shan Lee; Colin Phipps; Yeow Tee Goh; Kar Ying Yong; Xin Liu; Wee Joo Chng; Soon Thye Lim; Chandramouli Nagarajan
Journal:  Blood Cancer J       Date:  2021-08-12       Impact factor: 11.037

9.  Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report.

Authors:  Lars Kurch; Thomas W Georgi; Astrid Monecke; Daniel Seehofer; Gudrun Borte; Osama Sabri; Regine Kluge; Simone Heyn; Matthias Pierer; Uwe Platzbecker; Sabine Kayser
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.